# PI3K isoform-selective inhibitors: next-generation targeted cancer therapies

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/pi3k-isoform-selective-inhibitors-next-generation-targeted-cancer-therapies/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Xiang Wang,Jian Ding,Linghua Meng |
| Citations | 124 |
| DOI | 10.1038/aps.2015.71 |
| Fields | Biochemistry, Genetics and Molecular Biology,Medicine |
| Open Access | true |
| OA Status | bronze |
| OA URL | https://www.nature.com/articles/aps201571.pdf |
| OpenAlex ID | https://openalex.org/W2398183597 |
| PMID | 26364801 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Xiang Wang](https://scholariq.org/researchers/xiang-wang/)

## Paper journal

- [Acta Pharmacologica Sinica](https://scholariq.org/journals/acta-pharmacologica-sinica/)

## Paper primary topic

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)

## Paper topics

- [Chronic Lymphocytic Leukemia Research](https://scholariq.org/topics/chronic-lymphocytic-leukemia-research/)
- [PI3K/AKT/mTOR signaling in cancer](https://scholariq.org/topics/pi3k-akt-mtor-signaling-in-cancer/)
- [Chronic Myeloid Leukemia Treatments](https://scholariq.org/topics/chronic-myeloid-leukemia-treatments/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.